Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells
Authors
Keywords
-
Journal
IMMUNOLOGIC RESEARCH
Volume 69, Issue 6, Pages 558-567
Publisher
Springer Science and Business Media LLC
Online
2021-09-24
DOI
10.1007/s12026-021-09237-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CircRNAs in lifespan
- (2020) Kim Baumann NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab
- (2020) Jie Li et al. Molecular Cancer
- CircRNAs in anticancer drug resistance: recent advances and future potential
- (2020) Tianwei Xu et al. Molecular Cancer
- Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells
- (2019) Mengjie Zhao et al. ONCOLOGY REPORTS
- Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
- (2019) Yiqun Han et al. Cancer Management and Research
- circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
- (2019) Yiran Liang et al. ONCOGENE
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Circular RNAs in drug resistant tumors
- (2019) Xin Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- Towards personalized treatment for early stage HER2-positive breast cancer
- (2019) Kristina Goutsouliak et al. Nature Reviews Clinical Oncology
- CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis
- (2018) Jie Wu et al. CANCER LETTERS
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis
- (2018) Honglei Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- circRNA disease: a manually curated database of experimentally supported circRNA-disease associations
- (2018) Zheng Zhao et al. Cell Death & Disease
- Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
- (2018) Longqiang Wang et al. Molecular Cancer
- Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β‑catenin signaling pathway
- (2018) Hongfei Zhang et al. Oncology Letters
- Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer
- (2017) Lingshuang Lü et al. Oncotarget
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Natural RNA circles function as efficient microRNA sponges
- (2013) Thomas B. Hansen et al. NATURE
- Circular RNAs are a large class of animal RNAs with regulatory potency
- (2013) Sebastian Memczak et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search